General Information of the Compound
| Compound ID |
CP0431683
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(4-Hexyl-3,5-dioxo-[1,2,4]triazolidin-1-yl)-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H36N6O5S
|
||||||||||||||||||
| Molecular Weight |
580.711
|
||||||||||||||||||
| Canonical SMILES |
CCCCCCn1c(=O)[nH]n(-c2ccc(cc2)S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H36N6O5S/c1-2-3-4-5-19-34-28(37)32-35(29(34)38)25-12-14-26(15-13-25)41(39,40)33-24-10-8-22(9-11-24)16-18-31-21-27(36)23-7-6-17-30-20-23/h6-15,17,20,27,31,33,36H,2-5,16,18-19,21H2,1H3,(H,32,37)/t27-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VFWQUQCFDQRHGW-MHZLTWQESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor